Dr. Falk PharmaFalk Foundation
  • About us
    About us
    • Now into the future
    • Innovation drives everything
    • Why we are
    • Corporate Sustainability
    • Following the footsteps of our founder
    • Global presence & business partners
  • Indications
    Indications
    • Autoimmune Hepatitis
    • Chronic Constipation
    • Colonoscopy
    • Crohn’s Disease
    • Eosinophilic Esophagitis
    • Hemorrhoidal disease
    • Irritable Bowel Syndrome
    • Microscopic Colitis
    • Primary Biliary Cholangitis
    • Ulcerative colitis
  • Our Products
  • Partnering
  • Newsroom
Search
Please choose your country
  • Global (English)
  • Australia
  • België (Vlaams)
  • Belgique (Français)
  • Deutschland
  • España
  • France
  • Ireland
  • Italia
  • Luxembourg (Français)
  • Nederland
  • Österreich
  • Portugal
  • Россия
  • Schweiz (Deutsch)
  • Suisse (Français)
  • United Kingdom
more info

Contact:
Phone:+49 0761 1514 0 Fax:+49 0761 1514 321 Email: zentrale@drfalkpharma.de

  • Falk Foundation
  • Contact us
  • Events
  • Reporting adverse events
  • Falsified medicines regulations
  • Imprint
  • Data Privacy
  • Social media guidelines
  • About us
    • Now into the future
    • Innovation drives everything
    • Why we are
    • Corporate Sustainability
    • Following the footsteps of our founder
    • Global presence & business partners
  • Indications
    • Autoimmune Hepatitis
    • Chronic Constipation
    • Colonoscopy
    • Crohn’s Disease
    • Eosinophilic Esophagitis
    • Hemorrhoidal disease
    • Irritable Bowel Syndrome
    • Microscopic Colitis
    • Primary Biliary Cholangitis
    • Ulcerative colitis
  • Our Products
  • Partnering
  • Newsroom
  • Falk Foundation
  • Contact us
  • Events
  • Reporting adverse events
  • Falsified medicines regulations
  • Imprint
  • Data Privacy
  • Social media guidelines
Contact:
Phone:
+49 0761 1514 0
Fax:
+49 0761 1514 321
Email:
zentrale[at]drfalkpharma.de
  • Homepage
  • Search

Search results

109 results

  • 404
    Homepage Events 404 Homepage 404 Sorry, the page you requested was not found. Back to homepage Homepage Events 404 Homepage 404 Sorry, the page you requested was not found. Back to homepage
  • NEWSROOM
    IBD Quiz Results
    WOW! What a well-informed community we have!
  • Social media guidelines
    Social media guidelines Homepage Social media guidelines Interested in following us on social media and keeping up to date with our latest news, comments and posts? Then simply like or follow us on:…
  • NEWSROOM
    Have difficulty swallowing food?
    Difficulty swallowing and pain while eating may be warning signs of eosinophilic esophagitis (EoE). The first EoE Day will be held on May 22, 2022.
  • NEWSROOM
    NAFLD: Phase 2a proof of concept study of ZED1227
    Dr. Falk Pharma and Zedira announce trial start for the treatment of non-alcoholic fatty liver disease. First patient enrolled in April.
  • NEWSROOM
    Response to the Ukraine crisis
    Dr. Falk Pharma supports APOTHEKER HELFEN e.V.
  • NEWSROOM
    GASL 2025
    See you at the 41st Annual Conference of the German Association for the Study of the Liver in Munich from 14.-15.02.2025!
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • »
Falk Foundation

Discover the range of continuing education opportunities for physicians and pharmacists provided by the Falk Foundation e.V.

Dr. Falk Pharma GmbH

Dr. Falk Pharma is the expert in digestive and metabolic medicine. As a research-based family business with global presence, we focus on the development and distribution of innovative medicines that improve patients’ health and well-being. 

  • Falk Foundation
  • Events
  • Headquarters
  • Reporting adverse events
  • Falsified medicines regulations
  • Social media guidelines
© 2025 Dr. Falk Pharma GmbH
  • Imprint
  • Data Privacy
Notice

This website is an international information resource intended for healthcare professionals outside the United States (US) and United Kingdom (UK).

I am a health care professional outside the US and UK.

Accept
Notice
I confirm I am a UK or Irish resident and have been prescribed either Budenofalk®, Jorveza®, Salofalk® or Ursofalk®
Accept

You are leaving the website of Dr. Falk Pharma.

We are not liable for the accuracy of any content published on third party websites - such as the one you are about to be forwarded to.